Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 4
SponsorUniversity of Zurich

About this trial

Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear benefits by coordinating support with the infant's own breathing. Recent studies indicate sNIPPV is superior to nsNIPPV in preventing respiratory failure, though the intrapulmonary mechanisms behind this advantage remain unclear. To address this, the present study uses Electrical Impedance Tomography (EIT) to evaluate how lung volume changes during different types of breaths and ventilator inflations - spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations - in preterm infants receiving sNIPPV.

Eligibility criteria

Qualifiers

Written informed consent by one or both parents or legal guardians

Gestational age at birth < 30 0/7 weeks

Infants on sNIPPV respiratory support

Below 4 weeks chronological age

Disqualifiers

Severe congenital malformation adversely affecting lung aeration or perfusion (e.g., congenital heart defects)

Too ill/unstable in the opinion of the treating physician.

Trial design

Treatments tested in this trial

  • Electrical Impedance Tomography (EIT)

Treatment groups

27 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Zurich

Lead sponsor

University Hospital, Zürich

Collaborator